LD 107
Session - 128th Maine Legislature
LR 525
Item 1
Bill Tracking, Additional Documents Chamber Status

An Act To Increase the Effectiveness of Opioid Addiction Therapy

Be it enacted by the People of the State of Maine as follows:

Sec. 1. 22 MRSA §3174-SS,  as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.

Sec. 2. 22 MRSA §3174-UU, sub-§7, ¶D,  as amended by PL 2013, c. 368, Pt. AAAAA, §1, is further amended to read:

D. A MaineCare member for whom MaineCare reimbursement for opioid drugs for the treatment of addiction is restricted by limits applicable to methadone and a MaineCare member who is receiving buprenorphine and naloxone combination drugs for the treatment of addiction; and


This bill repeals the 24-month limit on MaineCare coverage or reimbursement for buprenorphine and naloxone combination drugs, also known as Suboxone, for the treatment of addiction to opioids.

Top of Page